Start your intake Average Weight Loss Results from Semaglutide Trials The STEP clinical trial program, which evaluated semaglutide for chronic weight management, followed nearly 4,600 adults with obesity or overweight
In the U.S., common brand names of metformin include Glucophage, Glucophage XR, Glumetza, Fortamet, and Riomet
Our weight-loss program is designed to be safe, supportive, and effective
Both injection and oral formats are available to all 50 states without requiring health insurance, and both qualify as HSA and FSA eligible expenses
The WeightWatchers GLP-1 Program gives members comprehensive tools including: Daily nutritional targets, including protein, fruits and vegetables and hydration
In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)